Subscribe To
Morgan stanley says anti-obesity drugs have trimmed market value by $258bn
An interesting snippet from analysts at Morgan Stanely on a not-so-fat result:GLP-1 medications like Ozempic have seen a $340 billion uplift in market...
October 19, 2023, 10:20 pm
Terns pharmaceuticals to participate in upcoming investor conferences
FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
October 19, 2023, 8:05 pm
Ge healthcare teams up with novo nordisk to treat diabetes without drugs
GE HealthCare Technologies Inc. GEHC, -2.35% on Thursday said it is teaming up with Novo Nordisk NVO, -0.58% to develop an ultrasound treatment for ty...
October 19, 2023, 8:36 am
Viking therapeutics joins weight loss drug bandwagon as trial data impresses
Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatmen...
October 18, 2023, 7:06 am
Pepsico: strong growth driven by pricing and glp-1 anti-obesity drug is non-structural
PepsiCo has experienced strong net pricing growth over the past decade, driven by portfolio premiumization and innovative product offerings. Concerns ...
October 18, 2023, 1:19 am
Global market for anti-obesity drugs could reach $100b by 2030: goldman sachs
A report from Goldman Sachs predicts that the total addressable market globally for weight loss drugs could reach $100 billion dollars in sales by 203...
October 17, 2023, 5:35 pm
Earnings results: johnson & johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business
Company raises full-year profit and sales guidance and pursues multipronged strategy to address talc-powder litigation. Read Full Story The post Earni...
October 17, 2023, 3:08 pm
Snack maker mondelez int'l is down but not out
In an unprecedented battle between modern medicine and traditional snacks, Mondelez International, Inc. NASDAQ: MDLZ appears to be losing. Since a W...
October 16, 2023, 12:21 pm
Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at obesityweek®
– CT-388 administered once-weekly resulted in clinically meaningful weight loss and insulin sensitivity over a 4 week treatment period in participan...
October 15, 2023, 4:00 pm
U.s. physical therapy: positioned for market dominance amidst attractive valuations
USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, prima...
October 13, 2023, 6:16 pm
Scholar rock (srrk) up on pipeline advancement, stock offering
Scholar Rock (SRRK) rises on plans to advance SRK-439 for treating obesity and offering common stock....
October 13, 2023, 2:16 pm
Why scholar rock holding stock soared today
Scholar Rock announced it will advance the development of its obesity treatment, SRK-439, starting with...
October 12, 2023, 4:17 pm
Jim cramer is weighing out the risks of weight loss drugs
'Mad Money' host Jim Cramer takes a deep dive into the impact of obesity drugs on various sectors....
October 11, 2023, 7:36 pm
Eli lilly: the glp-1 opportunity, while increasingly recognized, is vastly underestimated
Eli Lilly is expected to receive FDA approval for tirzepatide, an obesity medication, and has two other...
October 11, 2023, 5:33 pm
Thyroid function test market thrives with a 4.2% cagr, predicted us$ 2.64 billion by 2033 | future market insights, inc.
The United States is projected to dominate the thyroid function test market, with a 3.5% CAGR from 2023 to 2033. Government-funded endocrinology resea...
October 11, 2023, 12:30 pm
Sugar substitute market predicted to reach us$ 28.57 billion by 2033: growth and trends | future market insights, inc.
Sugar substitutes gradually finding their place in the food and beverages industry. The market foresees exponential growth in the coming decade. Risin...
October 10, 2023, 4:30 pm
Eli lilly pipeline of obesity treatments is positioned to pay off beyond just mounjaro, analysts say
Shares of Eli Lilly and Co (NYSE:LLY) rose Friday after analysts at Bank of America reaffirmed its confidence in the company. The firm reiterated its ...
October 6, 2023, 3:01 pm
Coca-cola, pepsi: will weight loss drugs hit food and drink sector proifits?
An end may be in sight to America's national obesity epidemic. However, a slimline population probably...
October 6, 2023, 9:31 am
Wegovy class has higher gi side effect risk than older weight loss drug in study
Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage, and...
October 5, 2023, 2:31 pm
Eli lilly exec behind diabetes blockbuster set retire
Mike Mason, the executive vice president and president of Lilly Diabetes & obesity at Eli Lilly and Co ...
October 4, 2023, 8:34 am